Connection

IVAN ROSAS to Antibodies, Monoclonal, Humanized

This is a "connection" page, showing publications IVAN ROSAS has written about Antibodies, Monoclonal, Humanized.
Connection Strength

1.231
  1. Tocilizumab and remdesivir in hospitalized patients with severe COVID-19 pneumonia: a randomized clinical trial. Intensive Care Med. 2021 11; 47(11):1258-1270.
    View in: PubMed
    Score: 0.556
  2. Tocilizumab in Hospitalized Patients with Severe Covid-19 Pneumonia. N Engl J Med. 2021 04 22; 384(16):1503-1516.
    View in: PubMed
    Score: 0.533
  3. Prognostic and Predictive Biomarkers in Patients With Coronavirus Disease 2019 Treated With Tocilizumab in a Randomized Controlled Trial. Crit Care Med. 2022 03 01; 50(3):398-409.
    View in: PubMed
    Score: 0.143
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.